ATHE

Alterity Therapeutics
ATHE

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $494K invested in Alterity Therapeutics in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$49K
2
+$27.6K
3
+$15K
4
OIA
Optimum Investment Advisors
Illinois
+$3K
5
UBS Group
UBS Group
Switzerland
+$2.59K

Top Sellers

1
-$66K
2
-$2.44K
3
-$2K
4
LC
Landaas & Company
Wisconsin
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$404K
2
$49K
3
$15K
4
$13K
5
$5K
6
$3K
7
$2K
8
$2K
9
$1K
10
$177
11
–
12
–
13
–